circRNA basic information
circBase ID: hsa_circ_0057582
Name: hsa_circ_HECW2
Synonym: circ_0057582
Host Gene: HECW2
Genomic location(hg19): chr2:197135916-197172809:-
Genomic location(hg38): chr2:196271192-196308085:-
Subcellular localization: nucleus and cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007254
MONDO name: breast cancer
Disease details: breast cancer
Disease DO ID:
1612
Disease MeSH ID:
-
Disease NCIt ID:
C9335
Disease ICD11 ID:
1047754165
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

breast cancer tissues; adjacent normal tissues; NATs; serum; mouse xenografts

Cell lines:

MCF-10A; MDA-MB-231; MCF-7; THP-1; HEK-293T

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: hnRNPF, YAP, SOX9, ISG15
Associated microRNA: -
Biological function: circ_0057582 suppresses tumor growth, inhibits proliferation, migration and invasion, promotes apoptosis, and inhibits M2-type tumor-associated macrophage polarization in breast cancer.
Molecular mechanism: circ_0057582 binds to hnRNPF to negatively regulate YAP mRNA stability and reduce YAP/SOX9 signaling; it also binds ISG15 and promotes ISG15 protein degradation through autophagy, reducing secreted ISG15 and preventing macrophage M2 polarization.
Biological pathway or process:

Hippo/YAP (inhibits); autophagy (promotes); proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); immune regulation (promotes); macrophage polarization (inhibits); mRNA stability (inhibits); other pathway/process (other)

Detected method:
Q
M
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; Microarray; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Wound Healing Assay; IHC (Immunohistochemistry); IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; In Vivo Animal Model; Western Blot; ROC Analysis; Bioinformatics Analysis

Clinical significance:

circ_0057582 expression correlated with pathological type and serum circ_0057582 showed diagnostic potential for discriminating breast cancer patients from healthy donors, with improved performance when combined with CEA and CA-153.

Description:

circ_0057582 is a downregulated tumor-suppressive circRNA in breast cancer tissues, serum, and cell lines. It inhibits breast cancer growth, proliferation, migration, and invasion through binding hnRNPF and destabilizing YAP mRNA, thereby reducing SOX9. It also promotes autophagic degradation of ISG15 to reduce secreted ISG15 and suppress M2 polarization of tumor-associated macrophages, and shows potential as a serum diagnostic biomarker.

Confidence score:

0.8933

Other information
Title:

Circ_0057582 inhibits breast cancer progression via hnRNPF/YAP/SOX9 axis and M2 polarization in TAMs by autophagic degradation of ISG15.

Journal: Biochemical pharmacology
Published: 2026
PubMed ID: 41241017
Study type:

combined biological and clinical study

Data availability: GSE101124; Data will be made available on request
Code availability: -